Courtroom showdowns still face OxyContin maker Purdue Pharma LP and the family that owns it, but after a tentative settlement reached on Wednesday with thousands of US local governments and more than 20 states, the fight is to be less about the damage done by the company and more over how to divide its assets.
The agreement could be worth up to US$12 billion over time. That amount includes future profits for the company, the value of overdose antidotes it is developing and cash payments of US$3 billion to US$4.5 billion from the Sackler family.
The amount is contingent on the sale of the family’s international drug company, Mundipharma International Ltd, which, like Purdue, has been criticized for overselling the benefits of its powerful prescription opioid painkillers and understating the risks.
Photo: AP
Critics are fuming that the deal will not be worth close to the stated US$12 billion, that it would not force internal company documents to be made public and that it does not do enough to hold the company or its owners responsible.
“The idea that Purdue might get away without having to admit any wrongdoing flies in the face of every definition of justice and accountability known to the human race. It’s unconscionable,” said Ryan Hampton, a Los Angeles-based advocate for people in recovery from opioid addiction.
For the Stamford, Ohio-based company, one of the next steps is a bankruptcy filing, which would likely end lawsuits filed against the company by about 2,000 counties, municipalities, Native American tribes, unions and hospitals, along with nearly every US state.
Parities that do not sign onto the settlement could raise objections in bankruptcy court — and some states have made it clear that that is their plan.
On the other side, several attorneys general said that the agreement was a better way to ensure compensation from Purdue and the Sacklers than taking their chances if Purdue files for bankruptcy on its own.
However, even advocates of the deal cautioned that it is not yet complete.
“There’s still a lot of telephone calls going on. I think we see the outlines of a thing that might be, but it’s not yet,” Ohio Attorney General Dave Yost said in an interview.
Opioid addiction has contributed to the deaths of about 400,000 Americans in the past two decades, hitting many rural communities particularly hard.
The tentative agreement and expected bankruptcy filing would remove Purdue from the first federal trial over the opioids epidemic, scheduled to begin next month in Cleveland, Ohio.
In a statement, the company said that it “continues to work with all plaintiffs on reaching a comprehensive resolution to its opioid litigation that will deliver billions of dollars and vital opioid overdose rescue medicines to communities across the country impacted by the opioid crisis.”
Members of the Sackler family said in a statement that there are good reasons for governments to join the settlement.
“This is the most effective way to address the urgency of the current public health crisis and to fund real solutions, not endless litigation,” they said.
China has claimed a breakthrough in developing homegrown chipmaking equipment, an important step in overcoming US sanctions designed to thwart Beijing’s semiconductor goals. State-linked organizations are advised to use a new laser-based immersion lithography machine with a resolution of 65 nanometers or better, the Chinese Ministry of Industry and Information Technology (MIIT) said in an announcement this month. Although the note does not specify the supplier, the spec marks a significant step up from the previous most advanced indigenous equipment — developed by Shanghai Micro Electronics Equipment Group Co (SMEE, 上海微電子) — which stood at about 90 nanometers. MIIT’s claimed advances last
ISSUES: Gogoro has been struggling with ballooning losses and was recently embroiled in alleged subsidy fraud, using Chinese-made components instead of locally made parts Gogoro Inc (睿能創意), the nation’s biggest electric scooter maker, yesterday said that its chairman and CEO Horace Luke (陸學森) has resigned amid chronic losses and probes into the company’s alleged involvement in subsidy fraud. The board of directors nominated Reuntex Group (潤泰集團) general counsel Tamon Tseng (曾夢達) as the company’s new chairman, Gogoro said in a statement. Ruentex is Gogoro’s biggest stakeholder. Gogoro Taiwan general manager Henry Chiang (姜家煒) is to serve as acting CEO during the interim period, the statement said. Luke’s departure came as a bombshell yesterday. As a company founder, he has played a key role in pushing for the
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has appointed Rose Castanares, executive vice president of TSMC Arizona, as president of the subsidiary, which is responsible for carrying out massive investments by the Taiwanese tech giant in the US state, the company said in a statement yesterday. Castanares will succeed Brian Harrison as president of the Arizona subsidiary on Oct. 1 after the incumbent president steps down from the position with a transfer to the Arizona CEO office to serve as an advisor to TSMC Arizona’s chairman, the statement said. According to TSMC, Harrison is scheduled to retire on Dec. 31. Castanares joined TSMC in
EUROPE ON HOLD: Among a flurry of announcements, Intel said it would postpone new factories in Germany and Poland, but remains committed to its US expansion Intel Corp chief executive officer Pat Gelsinger has landed Amazon.com Inc’s Amazon Web Services (AWS) as a customer for the company’s manufacturing business, potentially bringing work to new plants under construction in the US and boosting his efforts to turn around the embattled chipmaker. Intel and AWS are to coinvest in a custom semiconductor for artificial intelligence computing — what is known as a fabric chip — in a “multiyear, multibillion-dollar framework,” Intel said in a statement on Monday. The work would rely on Intel’s 18A process, an advanced chipmaking technology. Intel shares rose more than 8 percent in late trading after the